Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity

Thrombosis Research

Volumn 134, Issue 3, 2014, Pages 737-741

  Lami, Donatella ^a   Cellai, Anna Paola ^b   Antonucci, Emilia ^a   Fiorillo, Claudia ^c   Becatti, Matteo ^c   Grifoni, Elisa ^a   Cenci, Caterina ^a   Marcucci, Rossella ^a   Mannini, Lucia ^b   Miniati, Massimo ^a   Abbate, Rosanna ^a   Prisco, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Clot lysis time; Fibrinolysis; Pulmonary embolism; Residual perfusion defects

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEART CATHETERIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; LUNG PERFUSION; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TIME; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT WITHDRAWAL;

EID: 84974849311     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.013     Document Type: Article

References (27)

1. P.D. Stein, A.Y. Yaekoub, F. Matta, M. Janjua, R.M. Patel, and L.R. Goodman et al. Resolution of pulmonary embolism on CT pulmonary angiography Am J Roentgenol 194 2010 1263 1268
2. B. Cosmi, M. Nijkeuter, M. Valentino, M.V. Huisman, L. Barozzi, and G. Palareti Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism Intern Emerg Med 6 2011 521 528
3. J.L. Alonso-Martínez, F.J. Anniccherico-Sánchez, M.A. Urbieta-Echezarreta, J.L. García-Sanchotena, and H.G. Herrero Residual pulmonary thromboemboli after acute pulmonary embolism Eur J Intern Med 23 2012 379 383
4. R. Golpe, L.A. de Llano, O. Castro-Añón, M. Vázquez-Caruncho, C. González-Juanatey, and M.C. Fariñas Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism Acta Radiol 53 2012 728 731
5. T. Lisman, P.G. de Groot, J.C.M. Meijers, and F.R. Rosendaal Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis Blood 105 2005 1102 1105
6. A.H. Guimarães, E.L. de Bruijne, T. Lisman, D.W. Dippel, J.W. Deckers, and D. Poldermans et al. Hypofibrinolysis is a risk factor for arterial thrombosis at young age Br J Haematol 145 2009 115 120
7. A. Undas, M. Cieśla-Dul, T. Dra̧żkiewicz, and J. Sadowski Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform Thromb Res 130 2012 184 187
8. A.P. Cellai, D. Lami, E. Antonucci, C. Fiorillo, M. Becatti, and B. Olimpieri et al. Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism Thromb Haemost 109 2013 565 567
9. M. Miniati, C. Fiorillo, M. Becatti, S. Monti, M. Bottai, and C. Marini et al. Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic Am J Respir Crit Care Med 181 2010 992 996
10. M. Miniati, C. Cenci, S. Monti, and D. Poli Clinical presentation of acute pulmonary embolism. A survey of 800 cases PLoS ONE 7 2012 e30891
11. M. Miniati, M. Pistolesi, C. Marini, G. Di Ricco, B. Formichi, and R. Prediletto et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED) Am J Respir Crit Care Med 154 1996 1387 1393
12. G. Meyer, M.A. Collignon, F. Guinet, A.A. Jeffrey, L. Barritault, and H. Sors Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism Eur J Nucl Med 17 1990 315 319
13. G. Simonneau, H. Sors, B. Charbonnier, Y. Page, J.P. Laaban, R. Azarian, and The THESEE Study Group et al. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism N Engl J Med 337 1997 663 669
14. M. Wartski, M.A. Collignon, and for the THESEE Study Group Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents J Nucl Med 41 2000 1043 1048
15. M. Miniati, S. Monti, M. Bottai, E. Scoscia, C. Bauleo, and L. Tonelli et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism Medicine (Baltimore) 85 2006 253 262
16. M. Miniati, S. Monti, E. Airò, R. Pancani, C. Bauleo, and B. Formichi et al. Accuracy of chest radiography in predicting pulmonary hypertension Thromb Res 133 2014 345 351
17. N. Galiè, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera et al. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 30 2009 2495 2537
18. A.M. Carter, C.M. Cymbalista, T.D. Spector, P.J. Grant, and Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study, on behalf of the Euro CLOT investigators Arterioscler Thromb Vasc Biol 27 2007 2783 2789
19. A.P. Cellai, D. Lami, A. Magi, A.A. Liotta, A. Rogolino, and E. Antonucci et al. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation Clin Appl Thromb Hemost 16 2010 337 344
20. T.A. Morris, J.J. Marsh, P.G. Chiles, W.R. Auger, P.F. Fedullo, and V.L. Woods Jr. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis Am J Respir Crit Care Med 173 2006 1270 1275
21. I. Palka, J. Nessler, B. Nessler, W. Piwowarska, W. Tracz, and A. Undas Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism Heart 96 2010 1114 1118
22. J.D. Mills, R.A. Ariëns, M.W. Mansfield, and P.J. Grant Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease Circulation 106 2002 1938 1942
23. M.E. Meltzer, T. Lisman, P.G. de Groot, J.C. Meijers, S. le Cessie, and C.J. Doggen et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 Blood 116 2010 113 121
24. I.M. Lang, J.J. Marsh, M.A. Olman, K.M. Moser, D.J. Loskutoff, and R.R. Schleef Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli Circulation 89 1994 2715 2721
25. A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydłowska, A. Skubiszak, and K. Ciepłuch et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
26. B. Blombäck Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis Thromb Res 83 1996 1 75
27. O. Sanchez, D. Helley, S. Couchon, A. Roux, A. Delaval, and L. Trinquart et al. Perfusion defects after pulmonary embolism: risk factors and clinical significance J Thromb Haemost 8 2010 1248 1255